DY
Therapeutic Areas
LianBio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Mavacamten | Obstructive Hypertrophic Cardiomyopathy (oHCM) | Approved (China NMPA Review) |
| TP-03 (lotilaner) | Demodex Blepharitis | Phase 3 |
| NBTXR3 | Locally Advanced Head and Neck Cancer | Phase 3 |
| TP-04 (lotilaner) | Meibomian Gland Disease | Phase 2 |
| Infigratinib | Achondroplasia | Phase 2 |
| LYT-100 (deupirfenidone) | Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 |